1. Medtech Insight

Abbott Buys Bigfoot Biomedical – But What Lurks In The Forest?

 
• By Barnaby Pickering

Abbott and Bigfoot Biomedical have worked as partners for more than half a decade but will now continue as one. Analysts are questioning whether the merger will simply be a tuck-in for Abbott, or enable it to release an insulin pump of their own.

bigfoot in the forest
• Source: Shutterstock

After more than six years of diabetes platform co-development, Abbott is acquiring Bigfoot Biomedical for an undisclosed price.

Bigfoot's Bigfoot Unity system is an insulin management platform that can integrate smart insulin pen caps with data from a continuous glucose monitor (CGM) to provide insulin dosing

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business